Pfizer's Lipitor Patent Invalidated In South Korea
A South Korean court has reportedly ruled against Pfizer Inc. in a patent suit over the blockbuster cholesterol-reducing drug Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article